New guidelines urge caution with ketamine use for mental health treatment

No­vo Nordisk’s semaglu­tide has hit a pair of pri­ma­ry end­points in a late-stage test in pa­tients with a trio of car­diometa­bol­ic con­di­tions, bol­ster­ing the com­pa­ny’s

Le­gal ex­perts an­tic­i­pate a “full range” of con­sti­tu­tion­al and statu­to­ry ar­gu­ments from drug­mak­ers that are joint­ly set to have their cas­es heard against the In­fla­tion